Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study.
Saved in:
| Title: | Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study. |
|---|---|
| Authors: | Chen J; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Xiao Z; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Zeng X; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Xiang N; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Luo R; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Chen R; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Lin B; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Ke H; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China., Gong T; Department of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China., Ji C; Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Fujian Provincial Clinical Research Center for Immune Skin Diseases, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Institute of Dermatology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.; Key Laboratory of skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, People's Republic of China. |
| Source: | Psoriasis (Auckland, N.Z.) [Psoriasis (Auckl)] 2025 Oct 17; Vol. 15, pp. 527-534. Date of Electronic Publication: 2025 Oct 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101709086 Publication Model: eCollection Cited Medium: Internet ISSN: 2230-326X (Electronic) Linking ISSN: 2230326X NLM ISO Abbreviation: Psoriasis (Auckl) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
